National Health Investors NHI Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number at other companies

MSCIMSCI

97K—

AmetekAME

1.6M-9.8%

Arthur J. GallagherAJG

3.1M—

L3Harris TechnologiesLHX

1.3M-32.2%

Mondelez InternationalMDLZ

12M-3.1%

General DynamicsGD

5.8M-11.6%

Other financials

Income statement

See full

Revenue$115.1M+28.9%

Net income$40.1M+17.4%

EPS (diluted)$0.82+10.8%

Balance sheet

See full

Cash & equivalents$24.9M-81.8%

Total debt$1.4B+8.4%

Total equity$1.5B+6.2%

Total assets$2.9B+3.8%

Cash flow

See full

Operating cash flow$53.4M+15.0%

Valuation

See full

Market cap$3.54B+16.1%

Profitability

See full

Operating margin50.1%—

Net margin36.9%-4.3pp

FCF margin70.1%—

Returns & leverage

See full

Return on equity10.1%-0.5pp

Debt / equity0.9×0.0×

Where this comes from

Reported directly by National Health Investors in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.

The official record: National Health Investors’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about National Health Investors's share based compensation arrangement by share based payment award options exercisable number.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is National Health Investors's share based compensation arrangement by share based payment award options exercisable number?: National Health Investors (NHI) reported share based compensation arrangement by share based payment award options exercisable number of $372.16K in Q1 2026.
How has National Health Investors's share based compensation arrangement by share based payment award options exercisable number changed year-over-year?: National Health Investors's share based compensation arrangement by share based payment award options exercisable number decreased by 60.4% year-over-year, from $940.87K to $372.16K.